OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Preventive Cardiology is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
COP27 Climate Change Conference: urgent action needed for Africa and the world	488
Integrating lipoprotein(a) into preventive cardiology: probably important to get the measurement right	287
Anabolic steroids in athletes: the interplay of hormones and inflammation leading to the heart’s vulnerability	244
Does early initiation of non-statin therapy, evolocumab with LDL-C <50mg/dL contribute to the reduction of hospital readmissions in patients with ACS?: a single center real world evidence from	202
Cardiorespiratory fitness in relation to systolic and diastolic function in patients with heart failure and chronic coronary syndromes	173
Sex specific association of body composition with sphingosine-1-phosphate levels-results from the study of health in pomerania (SHIP) analysis	119
Characteristics and risk of coronary-related events following hospitalisation for chronic coronary disease	118
Type D personality, cardiovascular risk factors and risk of recurrent major adverse cardiac events in outpatients with coronary heart disease	107
Evaluation of the age-related prevalence of cardiovascular risk factors to guide systematic long-term follow-up after preeclampsia	95
Exercise doppler Echocardiography of the right heart and pulmonary circulation in patients with cardiovascular risk factors: observations from the RIGHT Heart International NETwork (RIGHT-NET)	92
Modulation of sympathetic nervous system activity through various therapeutic approaches in patients with resistant hypertension and heart failure with preserved ejection fraction	84
Temporal trends and outcomes of cardiac rehabilitation after acute coronary syndrome in an asian population	80
Statin therapy eligibility in a large primary prevention cohort according to European Society of Cardiology Guidelines	79
Sports-related sudden cardiac arrest: a video analysis of characteristics and outcomes	79
Temporal trends in myocardial infarction case fatality: methodological challenges and prevention targets	73
The role of the arrhythmologist in a sports cardiology centre: the devil is in the detail	70
Secondary prevention of Coronary Heart Disease (CHD) in the Moroccan population. Survey of Risk Factor (SURF) CHD II Morocco	69
Enhancement of left ventricular compliance in twin pregnancy	68
Treatment of iron deficiency anemia after cardiac surgery	67
Carotid intima-media thickness progression and plaque formation in recreational male endurance athletes - a 10-year follow-up study	65
Genetic variants associated with cardiorespiratory symptoms of long COVID. The GINA-COVID study	65
Effects of a behavioral psychological intervention in addition to an exercise rehabilitation program in chronic heart failure patients	62
Effect of preventive training in cardiac transcriptoma in rats with pulmonary hypertension	60
Association of cardiorespiratory fitness measured by cardiopulmonary exercise testing with covid-19 positivity: a prospective register-based cohort study	60
Baroreflex: ready for prime-time?	59

Exercise cardiac magnetic resonance imaging in heart failure with preserved ejection fraction	56
Social networks as a predictor of cardiovascular disease incidence and mortality: 10-year observation of the Polish HAPIEE cohort	56
Effect of hybrid cardiac rehabilitation using a smart device: a randomized controlled trial	56
Modelling the long-term clinical outcomes of AI-enabled CCTA plaque quantification on preventive cardiovascular management	53
Differences in 10-year cardiovascular risk estimation using SCORE and SCORE2 risk prediction tools: a moderate risk country population analysis	51
Cardiovascular rehabilitation - determinants of long-term outcomes	48
Role of Integrated yoga like posture, breathing exercise, music, sattvic diet and bhagwad geeta for quit smoking and cardiovascular prevention as compare to still active smokers	48
Supraventricular tachycardia (SVT) and high troponin levels: patient characteristics and evaluation of coexisting coronary artery disease	47
An artificial intelligence model to predict 12-month mortality among patients with myocardial infarction	46
Impact of type D personality on clinical outcomes in Spanish patients with myocardial infarction	46
Safety and efficacy of antiplatelet cessation after transcatheter patent foramen ovale closure	45
Women-focused cardiac rehabilitation delivery around the world and program enablers to support broader implementation	45
Prolonged troponin elevation after high-intensity exercise may indicate coronary artery disease	44
Moderate-to-vigorous physical activity of HFrEF patients is strongly associated with age, but not with functional capacity (6MWT), ejection fraction, NYHA, NT-proBNP, sex or BMI	44
Effect of dapagliflozin on pro-oxidant/antioxidant balance and renal function in patients with diabetic kidney disease to reduce the risk of cardiovascular events	44
Prognostic significance of non-ischemic computational pressure-flow dynamics derived fractional flow reserve in stable coronary artery disease patients in LAD versus non-LAD artery lesions	42
Clinical and instrumental follow-up and return to sport after surgical correction of anomalous origin of coronary arteries in young athletes	42
Risk stratification in chronic coronary syndrome: real-world application of SMART and EUROASPIRE scores for treatment optimization	42